Reducing delirium in cardiac surgery patients in the ICU
The Use of Auditory-visual Stimulation to Reduce Delirium Rates in Intensive Care Patients Post-cardiac Surgery: a Feasibility Study
This study is testing a sensory stimulation program to see if it can help reduce delirium in patients recovering from heart surgery in the ICU.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Imperial College Healthcare NHS Trust Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT06355570 on ClinicalTrials.gov |
What this trial studies
This study aims to investigate the incidence of delirium in patients recovering from cardiac surgery in the ICU at Hammersmith Hospital. It employs a mixed methods approach, collecting data through patient medical records, qualitative interviews, and quality-of-life questionnaires. The study also implements a sensory stimulation program involving auditory-visual materials to potentially reduce delirium and improve patient outcomes. Participants include patients, their family members, and ICU nurses, with data collected over a 12-month period.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 undergoing cardiac surgery who can provide informed consent and speak English.
Not a fit: Patients under 18, those unable to consent, or with significant cognitive impairments will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery outcomes and quality of life for patients after cardiac surgery.
How similar studies have performed: Other studies have shown promising results with sensory stimulation approaches in ICU settings, suggesting potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
INCLUSION CRITERIA Patients * Female and male patients over the age of 18 * Participants speaking English language and having mental capacity to consent * Suitable to undergoing cardiac surgery at ICHT. Family Members/Friends * Nominated by the participant. * Be willing to record videos and participate in the study. Healthcare professionals - Critical Care Nurses that have provided direct care to at least one patient who received the study intervention EXCLUSION CRITERIA Patients * Female and male patients under the age of 18 * Unable to consent to the study pre-operatively * Significant hearing/visual impairment * Participants with learning disabilities, pre-existing delirium, dementia or other significant underlying cognitive morbidity * Moribund participants, likely to die in the next 24 hours * Participants that do not speak English language Family Members/Friends * Refuse to consent or gain assent * Significant hearing/visual impairment * Family members/friends that do not speak English language Healthcare professionals * Critical care nurses that have not been involved in the implementation of the intervention * Refuse to consent or gain assent * Significant hearing/visual impairment and non-English speaking WITHDRAWAL CRITERIA: Participants * No longer willing to participate after consent * Personal consultee wishing to withdraw participants from the study * Patients that the clinical and/or research team deem too distressed to continue participating in the study * Patients who have lost the capacity to participate in the study after hospital discharge
Where this trial is running
London
- Imperial College Healthcare NHS Trust — London, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Maria Reguenga, BSN — Imperial College Healthcare NHS Trust
- Study coordinator: Maria Reguenga, BSN
- Email: maria.reguenga@nhs.net
- Phone: 07585095566
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.